Phosphorus-Binding Composition for Periparturient Ruminant Hypocalcemia Risk Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for a method to precisely adjust the phosphorus to aluminum (P:Al) ratio in the feeds of dairy cows to maintain desired blood phosphorus concentrations and reduce the risk of periparturient hypocalcemia.

Innovation Solution

A method involving the measurement of blood phosphorus concentration in periparturient ruminant animals, followed by the administration of a composition containing a phosphorus-binding compound, such as an aluminum compound, to control blood phosphorus levels within a specific range (1.5-3.5 mg P per dL) during the prepartum period.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If aluminum-based phosphorus binders are fed to periparturient cows, then blood phosphorus concentration is reduced and calcium homeostasis is improved, but the P:Al ratio in feeds is inconsistent and varies considerably from farm to farm

Engineering Contradiction:
Improvecalcium homeostasisVSAvoidP:Al ratio consistency
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The invention changes the key parameter from variable P:Al ratios to a fixed aluminum concentration (50-150 ppm Al in dry matter). This standardization eliminates the inconsistency in P:Al ratios while maintaining the therapeutic effect on blood phosphorus and calcium homeostasis.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention implements a feedback mechanism by monitoring blood phosphorus concentrations and adjusting aluminum binder supplementation accordingly. This ensures that the aluminum concentration is optimized to achieve the desired blood phosphorus range (1.5-3.5 mg/dL) while maintaining consistent P:Al ratios.

Inventive Principle:
Principle #23Feedback

2Reliability

If dietary phosphorus is bound using aluminum-based products, then blood phosphorus is reduced stimulating homeostatic mechanisms, but optimizing the rate and amount of phosphorus to bind in relation to aluminum provides challenge

Engineering Contradiction:
Improvehomeostatic mechanism stimulationVSAvoidfeeding optimization complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention simplifies the feeding optimization by changing from variable P:Al ratio formulations to a standardized aluminum concentration range (50-150 ppm Al in dry matter). This eliminates the complexity of optimizing P:Al ratios while maintaining effective stimulation of homeostatic mechanisms through controlled phosphorus binding.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If blood phosphorus concentration is controlled within a specific range, then risk of hypocalcemia is reduced, but precise measurement and adjustment of phosphorus levels is required

Engineering Contradiction:
Improvehypocalcemia risk reductionVSAvoidblood phosphorus measurement
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The invention establishes a specific target range for blood phosphorus concentration (1.5-3.5 mg/dL) and maintains aluminum supplementation within a defined range (50-150 ppm Al in dry matter). These standardized parameter ranges enable reliable hypocalcemia prevention while providing clear guidelines for measurement and adjustment.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively reduces the risk of hypocalcemia by maintaining blood phosphorus concentrations within a targeted range, thereby supporting calcium homeostasis and overall cow health.

Implementation Method 1

The composition comprises an effective amount of the phosphorus-binding compound to control the blood phosphorus concentration in a range of 1.5-3.5 mg P per dL of blood

Methodology Applied
Scientific EffectPhosphorus binding: Adsorption

Data Source

PatentUS12310984B1Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals
Publication Date: 2025.05.27 VILOFOSS AS
  • US12310984B1 patent drawing
  • US12310984B1 patent drawing

AI summary

A method of reducing risk of periparturient hypocalcemia in a periparturient ruminant animal involves: measuring blood phosphorus concentration in the animal; and, administering a composition containing a phosphorus-binding compound and optionally, a pharmacologically acceptable carrier to the animal during at least part of a prepartum period of the animal, the composition having an effective amount of the phosphorus-binding compound to control the blood phosphorus concentration in a range of 1.5-3.5 mg P per dL of blood in the animal.